Volatile anaesthetics have historically been considered to act in a no
nspecific manner on the central nervous system(1,2). More recent studi
es, however, have revealed that the receptors for inhibitory neurotran
smitters such as gamma-aminobutyric acid (GABA) and glycine are sensit
ive to clinically relevant concentrations of inhaled anaesthetics(3).
The function of GABAA and glycine receptors is enhanced by a number of
anaesthetics(4-9) and alcohols(10-12), whereas activity of the relate
d(13) GABA rho 1 receptor is reduced(14). We have used this difference
in pharmacology to investigate the molecular basis for modulation of
these receptors by anaesthetics and alcohols. By using chimaeric recep
tor constructs, we have identified a region of 45 amino-acid residues
that is both necessary and sufficient for the enhancement of receptor
function. Within this region, two specific amino-acid residues in tran
smembrane domains 2 and 3 are critical for allosteric modulation of bo
th GABA(A) and glycine receptors by alcohols and two volatile anaesthe
tics. These observations support the idea that anaesthetics exert a sp
ecific effect on these ion-channel proteins, and allow fbr the future
testing of specific hypotheses of the action of anaesthetics.